RACHEL MCHENRY: Open Payments
NPI 1477595593 · HERMITAGE, TN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,754 in 76 payments from 14 companies in 2025. Trend: 2023 $1,845 · 2024 $1,615 · 2025 $1,754
Food & beverage: $1,754
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 22 | $488 |
| GlaxoSmithKline, LLC. | 11 | $230 |
| Astellas Pharma US Inc | 11 | $210 |
| REVANCE THERAPEUTICS, INC. | 2 | $186 |
| PFIZER INC. | 9 | $171 |
| AstraZeneca Pharmaceuticals LP | 7 | $143 |
| ABBVIE INC. | 5 | $120 |
| Exact Sciences Corporation | 3 | $56 |
| CeQur Corporation | 1 | $38 |
| Smith+Nephew, Inc. | 1 | $27 |
Products named: TRELEGY ELLIPTA, Wegovy, Veozah, Ozempic, DAXXIFY, NURTEC ODT, UBRELVY, BREZTRI.
Industry payments across TN — which companies pay providers there.
